Amicus Therapeutics
FOLD
#3908
Rank
โ‚ฌ2.62 B
Marketcap
8,50ย โ‚ฌ
Share price
-0.50%
Change (1 day)
-7.78%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2025 (TTM): -0,09941ย โ‚ฌ

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,09448ย โ‚ฌ. In 2014 the company made an earnings per share (EPS) of -0,80ย โ‚ฌ.

EPS history for Amicus Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,09941ย โ‚ฌ
2014-0,80ย โ‚ฌ
2012-0,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
9,44ย โ‚ฌ-10,090.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
2,34ย โ‚ฌ-2,572.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,46ย โ‚ฌ 390.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-3,369.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-0,16ย โ‚ฌ 72.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
3,02ย โ‚ฌ-3,294.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark